{"title":"PHOMS: un acrónimo apto y preciso","authors":"","doi":"10.1016/j.oftal.2024.04.011","DOIUrl":"10.1016/j.oftal.2024.04.011","url":null,"abstract":"","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 10","pages":"Pages 464-466"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141395323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Percepción de los pacientes con afección de retina sobre aspectos de la función visual y su manejo","authors":"","doi":"10.1016/j.oftal.2024.05.008","DOIUrl":"10.1016/j.oftal.2024.05.008","url":null,"abstract":"<div><h3>Background and objective</h3><div>Age-related macular degeneration (AMD) and diabetic retinopathy (DR) are highly prevalent.</div></div><div><h3>Objective</h3><div>To explore perceptions of patients with AMD or DR about the impact of the disease and treatment on their daily living activities.</div></div><div><h3>Materials and methods</h3><div>Semi-structured interviews with a questionnaire developed from validated patient reported outcomes questionnaires. The questionnaire consisted of 19 questions about the disease and 9 about the treatment. The questions (items) were answered on a scale from 1 to 9. In addition, the patient interviewed was invited to make free comments on each question. Nine patients with AMD and 9 with DR were interviewed by videoconference or telephone call. A quantitative analysis of the responses and a qualitative analysis of the comments were carried out.</div></div><div><h3>Results</h3><div>The most relevant item for patients with AMD or DR is “Recognize people when they are nearby”, and “Read text in normal size font in a newspaper or book”, followed, in patients with AMD, by “Do things what you would like” and, in patients with DR, “Feeling frustrated by the vision problems”. Regarding the treatment, the most relevant aspects for both groups is that the treatment works and receiving appropriate information before and after the treatment. The qualitative comments were focused to the disease, the treatment, and to the role of doctors and the health system.</div></div><div><h3>Conclusion</h3><div>Quantitative responses and free comments can be useful to improve the care of patients with AMD or DR by physicians and the health system.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 10","pages":"Pages 427-435"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141395839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neuropatía óptica isquémica anterior no arterítica como única manifestación de una crisis hipertensiva maligna: presentación de un caso","authors":"","doi":"10.1016/j.oftal.2024.04.009","DOIUrl":"10.1016/j.oftal.2024.04.009","url":null,"abstract":"<div><div>Non-arteritic anterior ischemic optic neuropathy (NAION) is after glaucoma the most common optic neuropathy in patients over 50<!--> <!-->years. It is known that high blood pressure (HBP) is an important risk factor for the development of NAION. It is also known that malignant arterial hypertension (MAH) could be accompanied by optic disc edema. However, MAH has not classically been considered a cause of NAION. We report the case of a 32-year-old patient who presented irreversible visual loss with a pattern compatible with NAION as the only manifestation of a hypertensive crisis.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 10","pages":"Pages 450-454"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141039880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efectividad de la válvula de Ahmed® implantada vía pars plana en pacientes con glaucoma refractario","authors":"","doi":"10.1016/j.oftal.2024.05.007","DOIUrl":"10.1016/j.oftal.2024.05.007","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the success rate and complications of the Ahmed® FP7 valve implanted via Pars Plana in a group of vitrectomized patients with refractory glaucoma and anterior segment abnormalities from January 2018 to June 2023.</div></div><div><h3>Methods</h3><div>Quasi-experimental, prospective study. Eleven eyes with refractory glaucoma were included. Participants underwent a comprehensive ophthalmic examination, including assessment of intraocular pressure (IOP) reduction, visual acuity, characterization of glaucoma type, and number of antiglaucoma medications.</div></div><div><h3>Results</h3><div>The mean baseline IOP was 37.3<!--> <!-->±<!--> <!-->11<!--> <!-->mmHg, which decreased to 13.5<!--> <!-->±<!--> <!-->3.0<!--> <!-->mmHg after one year. The qualified success rate was 63.7%, while the complete success rate was 36.3%. The most common diagnosis was neovascular glaucoma in 36.4% of cases. The most frequent postoperative complications were choroidal detachment and hypotony.</div></div><div><h3>Conclusions</h3><div>Our data suggest that implantation of the Ahmed FP7 valve via pars plana is an effective and safe option for patients with refractory secondary glaucoma.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 10","pages":"Pages 420-426"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141391489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Precisión de fórmulas para cálculo de LIO en pacientes con queratometrías promedio mayores de 46 dioptrías","authors":"","doi":"10.1016/j.oftal.2024.05.004","DOIUrl":"10.1016/j.oftal.2024.05.004","url":null,"abstract":"<div><h3>Objective</h3><div>To compare the accuracy of Kane, Barrett Universal<!--> <!-->II, Haigis, and SRK-T formulas in eyes with average keratometry greater than 46 diopters (D).</div></div><div><h3>Methods</h3><div>A retrospective analysis was conducted on 101 eyes of 101 patients with average keratometry greater than 46<!--> <!-->D. The absolute prediction error (EA) was obtained for each patient one month after surgery. The mean absolute prediction error (MEA), median absolute prediction error (MedEA) and the percentage of patients with absolute refractive error less than 0.25<!--> <!-->D, 0.50<!--> <!-->D, and 1.00<!--> <!-->D were calculated for each formula analyzed.</div></div><div><h3>Results</h3><div>The Kane formula achieved the lowest MEA (0.53<!--> <!-->±<!--> <!-->0.43) and the lowest MedEA (0.41), followed by Barrett Universal<!--> <!-->II (MEA: 0.56<!--> <!-->±<!--> <!-->0.42, MedEA: 0.49), SRK-T (MEA: 0.59<!--> <!-->±<!--> <!-->0.44, MedEA: 0.54), and Haigis (MEA: 0.77<!--> <!-->±<!--> <!-->0.47, MedEA: 0.69), showing a significant difference in the results. It was also observed that the Kane formula was the most accurate, with the highest percentage of patients, with EA less than 0.25<!--> <!-->D, 0.50<!--> <!-->D, and 1.00<!--> <!-->D (30.7%, 54.4%, and 86.1%, respectively), while the Haigis formula was the least accurate (12.9%, 33.7%, and 69.3%, respectively).</div></div><div><h3>Conclusion</h3><div>In eyes with corneas having average keratometry greater than 46<!--> <!-->D, the Kane formula proves to be a useful tool in intraocular lens (IOL) power calculation and demonstrates higher precision compared to the Barrett Universal<!--> <!-->II, SRK-T, and Haigis formulas.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 10","pages":"Pages 413-419"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141397188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Atrofia girata de la coroides y la retina: actualización en diagnóstico y tratamiento","authors":"","doi":"10.1016/j.oftal.2024.03.006","DOIUrl":"10.1016/j.oftal.2024.03.006","url":null,"abstract":"<div><p>Gyrate atrophy of the choroid and retina (GACR) is a rare autosomal recessive disease characterised by elevated plasma ornithine levels due to deficiency of the enzyme ornithine aminotransferase (OAT). The accumulation of this amino acid in plasma leads to the development of patches of chorioretinal atrophy in the peripheral retina extending into the macular area. Patients usually present with night blindness followed by constriction of the visual field and, finally, decreased central vision and blindness. The disease is diagnosed by the presence of the characteristic clinical picture, the presence of hyperornithinaemia in plasma and the detection of mutations in the OAT enzyme gene. There is currently no effective gene therapy and the most common therapeutic intervention mainly involves dietary modifications with arginine restriction.</p><p>This article aims to summarise the pathogenesis, clinical and diagnostic findings and treatment options in patients with GACR.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 392-399"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140792129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"El «ictus de la retina»: un llamado a la acción para la conciencia y el tratamiento de las emergencias vasculares oculares","authors":"","doi":"10.1016/j.oftal.2024.03.009","DOIUrl":"10.1016/j.oftal.2024.03.009","url":null,"abstract":"","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 363-364"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140769093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mujer vigoréxica con pérdida severa bilateral de visión","authors":"","doi":"10.1016/j.oftal.2024.04.008","DOIUrl":"10.1016/j.oftal.2024.04.008","url":null,"abstract":"<div><p>We describe a 28-year-old Caucasian female with vigorexy, who had no previous ocular history. She presented with bilateral gradual painless reduction in vision over the past 3 weeks. She had been taking niacin supplements, averaging 500<!--> <!-->mg daily, for 7 years. Fundus examination revealed bilateral CME, which was confirmed by ocular coherence tomography scan. Fundus fluorescein angiography did not reveal any fluid leakage. Niacin supplementation was discontinued, and after 2 months, the CME had completely resolved, and the best corrected visual acuities improved to 1 in both eyes.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 408-411"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141056384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Rodríguez-Calvo-de-Mora , J. Giménez-Almenara-Amo , B. Mataix-Albert , M. Arias-Alcalá , J. García-Montesinos-Gutiérrez , C. Rocha-de-Lossada , R. Villalba-Montoro , M.S. Díaz-Gallardo , N. Cuende , A. Álvarez-Márquez
{"title":"Bancos de ojos públicos de Andalucía: una década de mejora continua","authors":"M. Rodríguez-Calvo-de-Mora , J. Giménez-Almenara-Amo , B. Mataix-Albert , M. Arias-Alcalá , J. García-Montesinos-Gutiérrez , C. Rocha-de-Lossada , R. Villalba-Montoro , M.S. Díaz-Gallardo , N. Cuende , A. Álvarez-Márquez","doi":"10.1016/j.oftal.2024.05.002","DOIUrl":"10.1016/j.oftal.2024.05.002","url":null,"abstract":"<div><h3>Objectives</h3><p>To show donation data, number of keratoplasties and the changes in transplant indications and techniques that occurred in Andalusia in the period from 2013 to 2022.</p></div><div><h3>Materials and methods</h3><p>The present work is a retrospective and descriptive study that included all keratoplasties performed between January 2013 and December 2022 in Andalusia, as well as the evolution of the cornea donation and transplant activity of the public and private hospitals pertaining to the waiting list management system of the Public Health System of Andalusia. Transplants performed in private centers with corneas from outside Andalusia were excluded.</p></div><div><h3>Results</h3><p>Cornea donation activity in Andalusia in the decade 2013-2022 has experienced a growth of more than 126%, while overall transplant activity has increased by 157% in public hospitals. Penetrating keratoplasty has decreased from 83% in 2013 to 43% in 2022, while lamellar techniques have increased from 17% to 57% in this same period. Since 2018, more lamellar transplants are performed than penetrating transplants. Regarding indications, endothelial conditions already represent the first cause of transplantation. In 2022 alone, the public Andalusian Eye Banks evaluated 1,054 corneas and prepared 281 endothelial grafts.</p></div><div><h3>Conclusion</h3><p>In the decade from 2013 to 2022 in Andalusia there has been an increase in donation activity and the number of keratoplasties. The public Eye Banks implementation in this period has played a key role in the widespread adoption of lamellar keratoplasty techniques and has enabled the transition to perform a greater number of lamellar keratoplasties compared to penetrating keratoplasty.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 383-391"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142098078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Experiencia con el uso de bevacizumab intravítreo en el manejo de la retinopatía del prematuro tipo I en un país latinoamericano","authors":"","doi":"10.1016/j.oftal.2024.03.012","DOIUrl":"10.1016/j.oftal.2024.03.012","url":null,"abstract":"<div><p>In retinopathy of prematurity (ROP) type<!--> <!-->I, the use of intravitreal bevacizumab (IVB), which is an inhibitor of endothelial growth factor (VEGF), has become popular despite not being a therapy approved by regulatory agencies. However, IVB has shown positive effects in halting disease progression at lower costs compared to other anti-VEGF therapies (ranibizumab or aflibercept). In this report, we present the experience during the treatment with IVB of 102 Colombian children with ROP type<!--> <!-->I, with a success rate of 98% (100). Complications occurred in 3.9% (4). Finally, we conclude that a single dose of IVB is an effective therapy for the management of ROP type<!--> <!-->I, with a lower risk of complications and retreatment.</p></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"99 9","pages":"Pages 400-403"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140779726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}